Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-001724

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Jan 18, 2019
Accepted (ET)
Jan 23, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 18, 2019S38,098$16.2813D1,785,088ISee Footnote
Common StockF1,F3Jan 18, 2019S743$16.2813D1,784,345ISee Footnote
Common StockF4,F5Jan 18, 2019S261$16.281D1,784,084ISee Footnote
Common StockF4,F6Jan 18, 2019S381$16.281D1,783,703ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses